Webinars

Watson Genomics from Quest Core: A Focused Approach to Solid Tumor Profiling

Author: Pai, Aditya, MSc MSc, MS, MBA, CGC (ABGC), Racke, Frederick K., MD, PhD.
Date: Tuesday, June 20, 2017
Category: Webinar
Description: Dr Fred Racke and Aditya Pai discuss the evolution of solid tumor testing, the clinical utility of solid tumor profiling and also describe Watson Genomics... Read more 

Breakthroughs in Alzheimer’s Disease Assessment: Quantitation of CSF Beta Amyloid 40 & 42

Author: Clarke, Nigel J., PhD
Date: Wednesday, June 14, 2017
Category: For Credit, Webinar
Description: Dr Clarke discusses the advantages in assessing Alzheimer’s disease by measurement of amyloid beta 42/40 ratio, describes an improved LC-MS/MS approach for quantitating amyloid beta... Read more 

Assessment and Management of Rapidly Progressive Dementia (RPD)

Author: Geschwind, Michael D., MD, PhD
Date: Monday, June 12, 2017
Category: For Credit, Webinar
Description: Dr Geschwind discusses when to consider a diagnosis, the differential diagnoses, proper evaluation, and reviews the various management strategies for RPD.

At... Read more 

Why the HCV Genotyping Test is Still Needed in the Era of Pan-Genotypic Drugs

Author: Reau, Nancy, MD
Date: Monday, June 12, 2017
Category: Webinar
Description: Dr Nancy Reau discusses why genotyping is still needed.

At the conclusion of this program, participants will be able to:
-Illustrate... Read more 

Insights into the Importance of Genetic Testing in Epilepsy

Author: Smith, Lacey, MS, CGC
Date: Monday, June 12, 2017
Category: Webinar
Description: Lacy Smith, genetic counselor with Boston Children’s Hospital’s Epilepsy Genetics Program and Athena Diagnostics’ genetic counselor Susan Hahn describes the etiology of epilepsy, and the... Read more 

Use of FibroTest® (Noninvasive) to Assess Liver Fibrosis in Place of Biopsy

Author: Alam, Imtiaz, MD
Date: Wednesday, May 17, 2017
Category: Webinar
Description: Dr Alam explains why noninvasive tests are an alternative to liver biopsy. Read more 

Black Box Warning: Hepatitis B Testing for Patients on Hepatitis C Direct Acting Antivirals

Author: Feld, Jordan, MD, MPH
Date: Tuesday, May 16, 2017
Category: Webinar
Description: Dr Jordan Feld, MD, MPH, explains the testing associated with black box warning and why additional testing is needed.

Read more 

True or False? Presumptive Drug Testing

Author: McClure, F. Leland, MSci, PhD, F-ABFT
Date: Thursday, April 20, 2017
Category: Webinar
Description: Dr. McClure describes presumptive drug testing, how to interpret presumptive test results, and discusses appropriate follow-up actions for presumptive drug testing.

At... Read more 

Quantitative HBsAg and its Role in Chronic Hepatitis B Patient Management

Author: Gish, Robert, MD
Date: Friday, April 07, 2017
Category: For Credit, Webinar
Description: Dr Gish explains how HBsAg Quantitative test can be used to phase disease and manage treatment of Hep B positive patients, discusses the testing for... Read more 

Tuberculosis Screening: Latest Developments in Diagnostic Testing

Author: Qasba, Sarojini Sonia, MD, MPH
Date: Monday, March 27, 2017
Category: For Credit, Webinar
Description: Dr. Qasba describes latent tuberculosis infection (LTBI) and identifies appropriate patients to be tested, discusses recently updated clinical practice guidelines for diagnosis of tuberculosis (TB)... Read more